Work

A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.3335.3335

Authors: John Koreth, Haesook T. Kim, Paulina B. Lange, Bhavjot Bindra, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Brett Glotzbecker, Jerome Ritz, Bruce R Blazar, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea

Institutions: Dana-Farber Cancer Institute, University of Minnesota

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980918225

FWCI: 0.214

Cites:

Cited by: 1

Related to: 10